Globe Life Inc. (NYSE:GL – Get Free Report) CEO James Matthew Darden sold 9,527 shares of the firm’s stock in a transaction dated Friday, February 27th. The stock was sold at an average price of $144.34, for a total transaction of $1,375,127.18. Following the completion of the sale, the chief executive officer owned 53,860 shares of the company’s stock, valued at $7,774,152.40. This trade represents a 15.03% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink.
Globe Life Trading Down 0.5%
NYSE:GL traded down $0.77 during mid-day trading on Friday, hitting $145.32. 504,950 shares of the stock traded hands, compared to its average volume of 513,973. The company has a quick ratio of 0.07, a current ratio of 0.07 and a debt-to-equity ratio of 0.41. Globe Life Inc. has a 52 week low of $109.38 and a 52 week high of $152.71. The stock has a market capitalization of $11.57 billion, a price-to-earnings ratio of 10.32 and a beta of 0.47. The firm’s 50 day moving average is $141.76 and its two-hundred day moving average is $138.69.
Globe Life (NYSE:GL – Get Free Report) last announced its earnings results on Wednesday, February 4th. The company reported $3.39 earnings per share (EPS) for the quarter, missing the consensus estimate of $3.44 by ($0.05). Globe Life had a net margin of 19.37% and a return on equity of 21.75%. The business had revenue of $1.52 billion for the quarter, compared to analysts’ expectations of $1.53 billion. During the same quarter last year, the firm earned $3.14 EPS. The firm’s quarterly revenue was up 3.6% on a year-over-year basis. Globe Life has set its FY 2026 guidance at 14.950-15.650 EPS. On average, equities research analysts predict that Globe Life Inc. will post 13.87 earnings per share for the current year.
Globe Life Increases Dividend
Analyst Ratings Changes
A number of equities research analysts have weighed in on the company. Morgan Stanley reaffirmed an “overweight” rating and set a $176.00 target price on shares of Globe Life in a research report on Monday, December 15th. TD Cowen restated a “buy” rating on shares of Globe Life in a research note on Thursday, December 11th. Truist Financial upped their price objective on shares of Globe Life from $158.00 to $180.00 and gave the stock a “buy” rating in a research note on Friday, February 6th. JPMorgan Chase & Co. increased their target price on shares of Globe Life from $180.00 to $181.00 and gave the stock an “overweight” rating in a report on Thursday, February 5th. Finally, Wells Fargo & Company boosted their price target on shares of Globe Life from $170.00 to $171.00 and gave the company an “overweight” rating in a report on Wednesday. Eight research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the stock. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $171.33.
Trending Headlines about Globe Life
Here are the key news stories impacting Globe Life this week:
- Positive Sentiment: Board raised the quarterly dividend to $0.33 (22.2% increase) and announced two new board members — supports income-focused investors and signals confidence in cash flow. GLOBE LIFE INC. DECLARES DIVIDEND AND ANNOUNCES APPOINTMENT OF TWO NEW BOARD MEMBERS
- Positive Sentiment: Wells Fargo published a positive price-forecast note on Globe Life, which can attract buyers and lend near-term support to the share price. Wells Fargo & Company Issues Positive Forecast for Globe Life (NYSE:GL) Stock Price
- Neutral Sentiment: Globe Life Field booked for an Eagles concert, which forced a local high school to reschedule prom — shows strong event demand and venue utilization but has minimal direct impact on insurance operations. Eagles concert at Globe Life Field moves Texas high school’s prom night date How an Eagles concert at Globe Life Field bumped a North Texas high school prom
- Neutral Sentiment: GL was included in a Zacks piece highlighting high-ROE stocks as resilient plays; such coverage may raise investor interest but is not a company-specific catalyst. Buy 5 Stocks With High ROE as Markets Dance Whimsically to the AI Tune
- Negative Sentiment: CEO James Matthew Darden sold 9,527 shares (~15% reduction in his reported ownership), a sizable insider sale that can spook some investors. SEC Form 4 – Darden sale
- Negative Sentiment: EVP Robert Edward Hensley sold 712 shares (~7.7% reduction in his holding), another insider sale that adds to selling pressure signals. SEC Form 4 – Hensley sale
- Negative Sentiment: TipRanks flagged Globe Life’s rising allocation to alternative assets as increasing volatility, capital strain and liquidity risk — a potential medium-term headwind for valuation if realized. Globe Life’s Growing Alternative Asset Bets Raise Volatility, Capital Strain and Liquidity Risk
Institutional Trading of Globe Life
Several hedge funds have recently made changes to their positions in the stock. Norges Bank bought a new position in shares of Globe Life during the second quarter worth about $157,722,000. Northwestern Mutual Wealth Management Co. boosted its stake in Globe Life by 34,786.0% during the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 881,919 shares of the company’s stock valued at $123,345,000 after purchasing an additional 879,391 shares during the period. AQR Capital Management LLC grew its position in Globe Life by 98.6% in the 2nd quarter. AQR Capital Management LLC now owns 1,402,690 shares of the company’s stock worth $174,340,000 after purchasing an additional 696,548 shares during the last quarter. Balyasny Asset Management L.P. acquired a new stake in shares of Globe Life in the third quarter valued at approximately $80,925,000. Finally, Westfield Capital Management Co. LP acquired a new stake in shares of Globe Life in the third quarter valued at approximately $61,569,000. Institutional investors own 81.61% of the company’s stock.
About Globe Life
Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.
The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.
Recommended Stories
- Five stocks we like better than Globe Life
- The gold chart Wall Street is terrified of…
- America’s 1776 happening again
- This makes me furious
- Buy this Gold Stock Before May 2026
- What a Former CIA Agent Knows About the Coming Collapse
Receive News & Ratings for Globe Life Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Globe Life and related companies with MarketBeat.com's FREE daily email newsletter.
